Publication rates of registered clinical trials in macular degeneration

Retina

Volumn 31, Issue 2, 2011, Pages 401-404

  Prenner, Jonathan L ^a,b   Driscoll, Sarah J ^b   Fine, Howard F ^a,b   Salz, David A ^c   Roth, Daniel B ^a,b  

^a ROBERT WOOD JOHNSON UNIVERSITY HOSPITAL   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Age related; clinical trials; macular degeneration; publication rates; registries

Indexed keywords

ARTICLE; CLINICAL TRIAL (TOPIC); EARLY TERMINATION OF CLINICAL TRIAL; EVALUATION; INTERVENTION STUDY; LAW; MEDICAL LITERATURE; MEDICAL RESEARCH; MEDLINE; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PHASE 4 CLINICAL TRIAL (TOPIC); PUBLICATION; REGISTER; RETINA MACULA AGE RELATED DEGENERATION;

BIBLIOMETRICS; CLINICAL TRIALS AS TOPIC; DATABASES, FACTUAL; HUMANS; MACULAR DEGENERATION; NATIONAL INSTITUTES OF HEALTH (U.S.); PEER REVIEW, RESEARCH; PUBLICATIONS; PUBMED; REGISTRIES; UNITED STATES;

EID: 79551526437     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3181eef2ad     Document Type: Article

References (7)

1. Laine C, Horton R, DeAngelis CD, et al. Clinical trial registration-looking back and moving ahead. N Engl J Med 2007;356:2734-2736.
2. Ramsey S, Scoggins J. Commentary: practicing on the tip of an information iceberg? Evidence of underpublication of registered clinical trials in oncology. Oncologist 2008;13:925-929.
3. The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research. Washington, DC: Department of Health, Education, and Welfare; 1979.
4. World Medical Association. Declaration of Helsinki: ethical principles for medical research involving human subjects, as amended by the 48th World Medical Assembly, Somerset West, Republic of South Africa, October 1996. Available at: http:// www.wma.net/en/30publications/10policies/b3/17c.pdf Accessed February 2010.
5. Food and Drug Administration Amendments Act of 2007: Public Law No. 110-185 Section 801; 2007.
6. Food and Drug Administration Modernization Act of 1997. Public Law No. 105-115 Section 113; 2007.
7. Zarin D, Tse T. Closing a loophole in the FDA Amendments Act. Science 2008;322:44-46.